Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Statistics

Total Valuation

ORGO has a market cap or net worth of $378.66 million. The enterprise value is $319.57 million.

Market Cap	378.66M
Enterprise Value	319.57M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ORGO has 126.85 million shares outstanding. The number of shares has decreased by -2.00% in one year.

Current Share Class	126.85M
Shares Outstanding	126.85M
Shares Change (YoY)	-2.00%
Shares Change (QoQ)	-4.44%
Owned by Insiders (%)	37.57%
Owned by Institutions (%)	38.46%
Float	55.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.58
PS Ratio	0.87
Forward PS	0.85
PB Ratio	1.60
P/TBV Ratio	1.91
P/FCF Ratio	n/a
P/OCF Ratio	87.24
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.70
EV / EBITDA	14.18
EV / EBIT	61.56
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.12.

Current Ratio	4.12
Quick Ratio	3.28
Debt / Equity	0.12
Debt / EBITDA	1.01
Debt / FCF	n/a
Interest Coverage	5.04

Financial Efficiency

Return on equity (ROE) is -4.92% and return on invested capital (ROIC) is 0.80%.

Return on Equity (ROE)	-4.92%
Return on Assets (ROA)	0.70%
Return on Invested Capital (ROIC)	0.80%
Return on Capital Employed (ROCE)	1.29%
Revenue Per Employee	$527,917
Profits Per Employee	-$23,507
Employee Count	869
Asset Turnover	0.99
Inventory Turnover	3.88

Taxes

Income Tax	-8.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.49% in the last 52 weeks. The beta is 1.85, so ORGO's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	-1.49%
50-Day Moving Average	4.68
200-Day Moving Average	3.57
Relative Strength Index (RSI)	28.82
Average Volume (20 Days)	2,141,037

Short Selling Information

The latest short interest is 11.77 million, so 9.28% of the outstanding shares have been sold short.

Short Interest	11.77M
Short Previous Month	10.21M
Short % of Shares Out	9.28%
Short % of Float	21.18%
Short Ratio (days to cover)	7.60

Income Statement

In the last 12 months, ORGO had revenue of $458.76 million and -$20.43 million in losses. Loss per share was -$0.16.

Revenue	458.76M
Gross Profit	347.99M
Operating Income	5.19M
Pretax Income	n/a
Net Income	-20.43M
EBITDA	22.53M
EBIT	5.19M
Loss Per Share	-$0.16

Balance Sheet

The company has $109.97 million in cash and $42.63 million in debt, giving a net cash position of $67.33 million or $0.53 per share.

Cash & Cash Equivalents	109.97M
Total Debt	42.63M
Net Cash	67.33M
Net Cash Per Share	$0.53
Equity (Book Value)	368.07M
Book Value Per Share	1.91
Working Capital	203.11M

Cash Flow

In the last 12 months, operating cash flow was $4.44 million and capital expenditures -$11.44 million, giving a free cash flow of -$7.00 million.

Operating Cash Flow	4.44M
Capital Expenditures	-11.44M
Free Cash Flow	-7.00M
FCF Per Share	-$0.06

Margins

Gross margin is 75.85%, with operating and profit margins of 1.13% and -3.46%.

Gross Margin	75.85%
Operating Margin	1.13%
Pretax Margin	-5.29%
Profit Margin	-3.46%
EBITDA Margin	4.91%
EBIT Margin	1.13%
FCF Margin	n/a

Dividends & Yields

ORGO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.00%
Shareholder Yield	2.00%
Earnings Yield	-5.28%
FCF Yield	-1.81%

Analyst Forecast

The average price target for ORGO is $5.50, which is 84.26% higher than the current price. The consensus rating is "Buy".

Price Target	$5.50
Price Target Difference	84.26%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ORGO has an Altman Z-Score of 3.89 and a Piotroski F-Score of 6.

Altman Z-Score	3.89
Piotroski F-Score	6